Sichuan Road & Bridge Group (600039.SH) won a bid for a project worth 60.625 billion yuan in the fourth quarter.
Sichuan Road and Bridge (600039.SH) disclosed its major operating data for the fourth quarter of 2024, with the company winning the bid in the fourth quarter...
Sichuan Road & Bridge Group (600039.SH) disclosed its main business data for the fourth quarter of 2024. The company won a total of 221 bidding projects in the fourth quarter, with a total amount of 60.625 billion yuan.
Related Articles
Shanghai Shyndec Pharmaceutical's subsidiary obtains the drug registration certificate for Tafurinol eye drops.
Tasly Pharmaceutical Group's subsidiary has obtained the registration certificate for bosentan dispersible tablets.
Huiyu Pharmaceutical (688553.SH) subsidiary's clinical trial application for injection HY07121 (subcutaneous injection) has been accepted.
Shanghai Shyndec Pharmaceutical's subsidiary obtains the drug registration certificate for Tafurinol eye drops.
Tasly Pharmaceutical Group's subsidiary has obtained the registration certificate for bosentan dispersible tablets.
Huiyu Pharmaceutical (688553.SH) subsidiary's clinical trial application for injection HY07121 (subcutaneous injection) has been accepted.
RECOMMEND
